OOMA INC Income Taxes Disclosure
Note 10: Income Taxes
The domestic and foreign components of income (loss) before income taxes were as follows (in thousands):
|
|
Fiscal Year Ended January 31, |
|
|||||||||
|
|
2026 |
|
|
2025 |
|
|
2024 |
|
|||
United States |
|
$ |
3,162 |
|
|
$ |
(6,126 |
) |
|
$ |
(491 |
) |
Foreign |
|
|
1,211 |
|
|
|
(15 |
) |
|
|
(2,322 |
) |
Income (loss) before income taxes |
|
$ |
4,373 |
|
|
$ |
(6,141 |
) |
|
$ |
(2,813 |
) |
Income tax (benefit) provision consisted of the following (in thousands):
|
|
Fiscal Year Ended January 31, |
|
|||||||||
|
|
2026 |
|
|
2025 |
|
|
2024 |
|
|||
Current: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
$ |
(19 |
) |
|
$ |
168 |
|
|
$ |
— |
|
State |
|
|
481 |
|
|
|
592 |
|
|
|
1,153 |
|
Foreign |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total current |
|
|
462 |
|
|
|
760 |
|
|
|
1,153 |
|
Deferred: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
|
(1,876 |
) |
|
|
— |
|
|
|
(2,661 |
) |
State |
|
|
(672 |
) |
|
|
— |
|
|
|
(470 |
) |
Foreign |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total deferred |
|
|
(2,548 |
) |
|
|
— |
|
|
|
(3,131 |
) |
Income tax (benefit) provision |
|
$ |
(2,086 |
) |
|
$ |
760 |
|
|
$ |
(1,978 |
) |
The income tax benefit of $2.1 million for fiscal 2026 was primarily attributable to the release of a $2.5 million valuation allowance on certain preexisting deferred tax assets realized as a result of deferred tax liabilities assumed in the Company's acquisition of Phone.com. The income tax benefit of $2.0 million for fiscal 2024 was primarily attributable to the release of a $3.1 million valuation allowance on certain preexisting deferred tax assets realized as a result of deferred tax liabilities assumed in the Company's acquisition of 2600Hz.
Rate Reconciliation
The Company adopted ASU 2023-09 Income Taxes (Topic 740): Improvements To Income Tax Disclosures' on a prospective basis beginning with the year ended January 31, 2026. The following table presents required disclosure pursuant to ASU 2023-09 and reconciles the Company's U.S. federal statutory tax amount and rate to its actual effective amount and rate for the year ended January 31, 2026 (dollars in thousands):
|
|
Fiscal Year Ended January 31, 2026 |
|
|||||
|
|
Amount |
|
|
Percent |
|
||
Federal tax at statutory rate |
|
$ |
918 |
|
|
|
21 |
% |
State income taxes, net of federal benefit (1) |
|
|
85 |
|
|
|
2 |
% |
Foreign tax effects |
|
|
|
|
|
|
||
Canada |
|
|
(254 |
) |
|
|
(6 |
)% |
Effect of cross-border tax laws |
|
|
|
|
|
|
||
Global intangible low-taxed income inclusion |
|
|
417 |
|
|
|
10 |
% |
Tax credits |
|
|
|
|
|
|
||
Research and development credits |
|
|
1,321 |
|
|
|
30 |
% |
Valuation allowance |
|
|
(4,827 |
) |
|
|
(110 |
)% |
Nondeductible Items |
|
|
|
|
|
|
||
Other contributing items |
|
|
69 |
|
|
|
2 |
% |
Transaction costs |
|
|
223 |
|
|
|
5 |
% |
Changes in unrecognized tax benefits |
|
|
(906 |
) |
|
|
(21 |
)% |
Other items |
|
|
(196 |
) |
|
|
(5 |
)% |
Stock based compensation |
|
|
1,063 |
|
|
|
24 |
% |
Total |
|
$ |
(2,086 |
) |
|
|
(48 |
)% |
(1) State taxes in Florida, Maryland, Michigan, Pennsylvania, Texas, Virginia, Minnesota, New York, New Hampshire, Kentucky, and Idaho made up the majority (greater than 50 percent) of the tax effect in this category.
The following table presents the required disclosures prior to the Company's adoption of ASU 2023-09 and reconciles the U.S. federal statutory income tax rate to the actual global effective income tax rate for the years ended January 31, 2025 and January 31, 2024 (in thousands):
|
|
Fiscal Year Ended January 31, |
|
|||||||||||||
|
|
2025 |
|
|
Rate |
|
|
2024 |
|
|
Rate |
|
||||
Federal tax at statutory rate |
|
$ |
(1,290 |
) |
|
|
21 |
% |
|
$ |
(603 |
) |
|
|
21 |
% |
State taxes, net of federal benefit |
|
|
(402 |
) |
|
|
7 |
% |
|
|
(128 |
) |
|
|
4 |
% |
Foreign income and withholding taxes |
|
|
284 |
|
|
|
(5 |
)% |
|
|
(139 |
) |
|
|
5 |
% |
Permanent tax adjustment |
|
|
(167 |
) |
|
|
3 |
% |
|
|
294 |
|
|
|
(10 |
)% |
Section 162(m) |
|
|
808 |
|
|
|
(13 |
)% |
|
|
802 |
|
|
|
(28 |
)% |
Stock-based compensation |
|
|
881 |
|
|
|
(14 |
)% |
|
|
812 |
|
|
|
(28 |
)% |
Change in valuation allowance |
|
|
2,669 |
|
|
|
(44 |
)% |
|
|
(1,015 |
) |
|
|
35 |
% |
Research and development credit |
|
|
(1,355 |
) |
|
|
22 |
% |
|
|
(2,095 |
) |
|
|
73 |
% |
Provision to return adjustments |
|
|
(834 |
) |
|
|
14 |
% |
|
|
4 |
|
|
|
— |
|
Other |
|
|
166 |
|
|
|
(3 |
)% |
|
|
90 |
|
|
|
(3 |
)% |
Income tax provision (benefit) at effective tax rate |
|
$ |
760 |
|
|
|
(12 |
)% |
|
$ |
(1,978 |
) |
|
|
69 |
% |
The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities are as follows (in thousands):
|
|
As of January 31, |
|
|||||
|
|
2026 |
|
|
2025 |
|
||
Deferred tax assets: |
|
|
|
|
|
|
||
Net operating loss carryforwards |
|
$ |
26,188 |
|
|
$ |
13,409 |
|
Tax credit carryover |
|
|
14,584 |
|
|
|
15,790 |
|
Operating lease liabilities |
|
|
3,844 |
|
|
|
3,993 |
|
Stock-based compensation |
|
|
555 |
|
|
|
626 |
|
Capitalized research and development |
|
|
16,419 |
|
|
|
23,148 |
|
State Taxes |
|
|
75 |
|
|
|
187 |
|
Deferred revenue |
|
|
4 |
|
|
|
3 |
|
Other |
|
|
88 |
|
|
|
— |
|
Gross deferred tax assets |
|
|
61,757 |
|
|
|
57,156 |
|
Valuation allowance |
|
|
(49,822 |
) |
|
|
(45,199 |
) |
Net deferred tax assets |
|
$ |
11,935 |
|
|
$ |
11,957 |
|
Deferred tax liabilities: |
|
|
|
|
|
|
||
Operating lease right-of-use assets |
|
$ |
(3,573 |
) |
|
$ |
(3,833 |
) |
Deferred sales commissions and other |
|
|
(2,055 |
) |
|
|
(2,138 |
) |
Acquired intangible assets |
|
|
(4,483 |
) |
|
|
(4,716 |
) |
Fixed assets depreciation |
|
|
(1,824 |
) |
|
|
(1,270 |
) |
Gross deferred tax liabilities |
|
$ |
(11,935 |
) |
|
$ |
(11,957 |
) |
Net deferred taxes |
|
$ |
— |
|
|
$ |
— |
|
Management believes that, based upon the available evidence, both positive and negative, it is more likely than not that the deferred tax assets will not be utilized, such that a full valuation allowance has been recorded. The net change in the total valuation allowance was an increase of $4.6 million and an increase of $2.7 million for fiscal 2026 and 2025, respectively.
As of January 31, 2026, the Company had net operating loss carryforwards for federal and state income tax purposes of approximately $81.4 million and $96.9 million, respectively, which will begin to expire in fiscal 2033 and fiscal 2029, with $79.4 million of federal net operating loss carryforward lasting indefinitely. In addition, as of January 31, 2026, the Company had federal and state research credit carryforwards of approximately $14.5 million and $13.1 million, respectively, available to offset future taxes. If not utilized, the available federal credits will begin to expire in fiscal 2030 and the state credits can be carried forward indefinitely.
The Company’s ability to utilize the domestic net operating losses (NOLs) and tax credit carryforwards may be limited due to ownership change limitations that may have occurred or that could occur in the future, as required by Internal Revenue Code Section 382, as well as similar state provisions. An “ownership change,” as defined by the code, results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders or public groups. Any limitation may result in expiration of all or a portion of the NOL or tax credit carryforwards before utilization.
Uncertain Tax Positions
The Company has unrecognized tax benefits of approximately $11.5 million as of January 31, 2026. Deferred tax assets associated with these unrecognized tax benefits are fully offset by a valuation allowance. If recognized, these benefits would not affect the effective tax rate before consideration of the valuation allowance.
The following table summarizes the activity related to unrecognized tax benefits (in thousands):
|
|
Fiscal Year Ended January 31, |
|
|||||||||
|
|
2026 |
|
|
2025 |
|
|
2024 |
|
|||
Unrecognized tax benefits, beginning of fiscal year |
|
$ |
12,134 |
|
|
$ |
11,043 |
|
|
$ |
9,060 |
|
(Decrease) increase related to prior year tax positions |
|
|
(906 |
) |
|
|
(252 |
) |
|
|
670 |
|
Increase related to current year tax positions |
|
|
240 |
|
|
|
1,343 |
|
|
|
1,313 |
|
Unrecognized tax benefits, end of fiscal year |
|
$ |
11,468 |
|
|
$ |
12,134 |
|
|
$ |
11,043 |
|
The Company had no interest or penalty accruals associated with uncertain tax benefits in its balance sheets and statements of operations. Because the Company has net operating loss and credit carryforwards, there are open statutes of limitations in which federal, state and foreign taxing authorities may examine the Company’s tax returns for all tax years from the fiscal year ended January 31, 2010 through the current period.
The Company files income tax returns in the U.S. federal, various state, and foreign jurisdictions with varying statutes of limitations. The Company is generally no longer subject to tax examinations for years prior to 2023 for federal purposes and 2022 for state purposes, except in certain limited circumstances.
The Company adopted ASU 2023-09 on a prospective basis for the year ended January 31, 2026 and has included the following table as a result of its adoption, which presents income taxes paid (net of refunds received) for the year ended January 31, 2026 (in thousands):
|
|
|
|
Fiscal Year Ended January 31, |
|
|
|
|
|
|
2026 |
|
|
Federal |
|
|
|
$ |
46 |
|
State and Local |
|
|
|
|
|
|
Texas |
|
|
|
|
88 |
|
Florida |
|
|
|
|
78 |
|
Pennsylvania |
|
|
|
|
76 |
|
Oregon |
|
|
|
|
47 |
|
Massachusetts |
|
|
|
|
46 |
|
Michigan |
|
|
|
|
45 |
|
All Other States |
|
|
|
|
313 |
|
Foreign |
|
|
|
|
— |
|
Income tax, net of amounts refunded |
|
|
|
$ |
739 |
|
The amount of cash income taxes paid by the Company during the years ended January 31, 2025 and January 31, 2024 was $0.6 million and $0.8 million, respectively.
On July 4, 2025, the U.S. government enacted The One Big Beautiful Bill Act of 2025 ("OBBBA") which includes, among other provisions, changes to the U.S. corporate income tax system including the allowance of immediate expensing of qualifying research and development expenses and permanent extensions of certain provisions within the Tax Cuts and Jobs Act. Certain provisions are effective for the Company beginning in fiscal year 2026. The Company determined that the OBBBA did not have a material impact on the financial statements for the year ended January 31, 2026.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Apr 3, 2026 | Showing above |
| 2025 | Apr 1, 2025 | |
| 2024 | Apr 2, 2024 | |
| 2023 | Apr 7, 2023 | |
| 2022 | Apr 8, 2022 | |
| 2021 | Apr 7, 2021 | |
| 2020 | Apr 14, 2020 | |
| 2019 | Apr 3, 2019 | |
| 2018 | Apr 2, 2018 | |
| 2017 | Apr 11, 2017 | |
| 2016 | Apr 13, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.